Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Examining patient outcomes after GLP-1 discontinuation The study used a retrospective cohort design and data from a large healthcare system in Ohio and Florida
This additional analysis used data from a trial in subjects with T2D (NCT02877355) [21], which was not included in the main model because not all dosing was supervised
It results in irregular heart rhythm and can lead to strokes
In adults with chronic kidney disease, it is used to help control blood sugar and to reduce the risk of cardiovascular and kidney-related complications
US$ 27.50
US$ 24.64
US$ 20.41
US$ 23.86
US$ 28.81
